Farmaceutica R (RMAH) — Net Asset Quality Index
Farmaceutica R (RMAH) has a Net Asset Quality Index of 21.1% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of RON384.68 Million minus total liabilities of RON303.69 Million yields net assets of RON80.99 Million. A higher index indicates a stronger, lower-leverage balance sheet. See RMAH defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Farmaceutica R Net Asset Quality Index Over Time (2020–2025)
This chart shows how Farmaceutica R's Net Asset Quality Index has evolved across 6 annual periods from 2020 to 2025. As of December 2025, the index stands at 21.1%, representing net assets of RON80.99 Million against total assets of RON384.68 Million RON. Also explore Farmaceutica R total assets for the complete picture of this company's asset base.
Annual Net Asset Quality Index for Farmaceutica R (2020–2025)
The table below presents the year-by-year Net Asset Quality Index for Farmaceutica R from 2020 to 2025, covering 6 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see RMAH market cap.
| Year | Quality Index | Net Assets (RON) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 21.1% | RON80.99 Million | RON384.68 Million | RON303.69 Million | ▲ +1.1 pp |
| 2024 | 19.9% | RON74.94 Million | RON376.03 Million | RON301.09 Million | ▼ -2.5 pp |
| 2023 | 22.4% | RON70.86 Million | RON315.76 Million | RON244.90 Million | ▼ -1.5 pp |
| 2022 | 23.9% | RON68.43 Million | RON286.20 Million | RON217.77 Million | ▼ -3.3 pp |
| 2021 | 27.2% | RON68.22 Million | RON251.07 Million | RON182.85 Million | ▼ -5.5 pp |
| 2020 | 32.7% | RON79.83 Million | RON244.46 Million | RON164.63 Million | — |